Literature DB >> 32881196

Antimicrobial resistance phenotypes and genotypes of Streptococcus suis isolated from clinically healthy pigs from 2017 to 2019 in Jiangxi Province, China.

M-F Tan1, J Tan1, Y-B Zeng1, H-Q Li1, Q Yang1, R Zhou2,3,4.   

Abstract

AIMS: This study aimed to investigate the antimicrobial resistance (AMR) profiles and genotypes of Streptococcus suis from Jiangxi Province, China. METHODS AND
RESULTS: A total of 314 nasal swab samples were collected from clinically healthy pigs, with a positive isolation rate of S. suis of 34·08%. Antimicrobial susceptibility testing showed that more than 80% of the isolates were susceptible to vancomycin, penicillin, minocycline and chloramphenicol. A high frequency of resistance to clindamycin, tetracycline, clarithromycin and erythromycin was observed. All of the isolates were resistant to three or more categories of antimicrobials. The erm(B) and tet(O) served as the most frequent genotypes that contributed to lincosamide, macrolide and tetracycline resistances. A part of macrolide-resistant genotypes could not exhibit specific phenotypes. Finally, integrative and conjugative elements (ICEs) were identified in 28·97% of the isolates.
CONCLUSIONS: The multidrug resistance of S. suis has widely emerged in Jiangxi Province. The most prevalent resistance genes and genotypes were similar to those in other regions or countries. The presence of ICEs is increasing the risk of horizontal transfer of AMR genes. SIGNIFICANCE AND IMPACT OF THE STUDY: The findings could provide guidance for the rational use of antimicrobial drugs and be helpful for monitoring the AMR information of S. suis in China.
© 2020 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Streptococcus suiszzm321990; China; antimicrobial resistance; clinically healthy pigs; genotype; integrative and conjugative elements; multidrug resistance

Mesh:

Substances:

Year:  2020        PMID: 32881196     DOI: 10.1111/jam.14831

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  A novel bicyclic 2,4-diaminopyrimidine inhibitor of Streptococcus suis dihydrofolate reductase.

Authors:  Warangkhana Songsungthong; Sunisa Prasopporn; Louise Bohan; Potjanee Srimanote; Ubolsree Leartsakulpanich; Suganya Yongkiettrakul
Journal:  PeerJ       Date:  2021-02-03       Impact factor: 2.984

2.  Identification and characterization of the cell division protein MapZ from Streptococcus suis.

Authors:  Muriel Dresen; Manfred Rohde; Jesús Arenas; Astrid de Greeff; Andreas Nerlich; Peter Valentin-Weigand
Journal:  Microbiologyopen       Date:  2021-10       Impact factor: 3.139

3.  Streptococcus suis TrpX is part of a tryptophan uptake system, and its expression is regulated by a T-box regulatory element.

Authors:  Muriel Dresen; Desirée Schaaf; Jesús Arenas; Astrid de Greeff; Peter Valentin-Weigand; Andreas Nerlich
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

4.  Effects of l-Serine on Macrolide Resistance in Streptococcus suis.

Authors:  Chunliu Dong; Yanhua Li; Tong Wu; Xiaozhen Wang; Yue Dong; Chen Xing; Xueying Chen; Lu Li
Journal:  Microbiol Spectr       Date:  2022-07-18

5.  Inhibitors targeting the autophosphorylation of serine/threonine kinase of Streptococcus suis show potent antimicrobial activity.

Authors:  Haotian Li; Tingting Li; Qiao Hu; Zhiming Yao; Lu Li; Qi Huang; Rui Zhou
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

6.  IPA-3: An Inhibitor of Diadenylate Cyclase of Streptococcus suis with Potent Antimicrobial Activity.

Authors:  Haotian Li; Tingting Li; Wenjin Zou; Minghui Ni; Qiao Hu; Xiuxiu Qiu; Zhiming Yao; Jingyan Fan; Lu Li; Qi Huang; Rui Zhou
Journal:  Antibiotics (Basel)       Date:  2022-03-21

7.  Antimicrobial Susceptibility of Streptococcus suis Isolated from Diseased Pigs in Thailand, 2018-2020.

Authors:  Kamonwan Lunha; Wiyada Chumpol; Sukuma Samngamnim; Surasak Jiemsup; Pornchalit Assavacheep; Suganya Yongkiettrakul
Journal:  Antibiotics (Basel)       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.